Skip to content

Anterior Segment Changes after pharmacologic Mydriasis in Primary angle closure suspects

Anterior Segment Changes after pharmacologic Mydriasis in Primary angle closure suspects

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-14004416
Enrollment
Unknown
Registered
2014-03-24
Start date
2014-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary angle closure glaucoma

Interventions

PACS(non-operation) vs PACS(afterLPI) vs normal:pharmacologic mydriasis

Sponsors

Department of Opthalmology, Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: PACS were defined as eyes with an angle in which more than 270 degree of the posterior trabecular meshwork (the part that often is pigmented) cannot be seen, without peripheral anterior synechiae, elevated intraocular pressure, iris whorling, glaukomfleken lens opacities, or optic disc damage. All control subjects were recruited from out patient service seen for fundus examination after mydriasis, who had open angles with grade 3–4 angle depths in the Shaffer classification.

Exclusion criteria

Exclusion criteria: All the subjects were not receiving any drops or medicine which may affect the iris or angle configuration during the study, had no history of intraocular surgery (LPI excluded), trauma and corneal disorders that precluded OCT or Pentacam imaging.

Design outcomes

Primary

MeasureTime frame
Anterior Segment parameter;

Countries

China

Contacts

Public ContactHong Zhang

Department of Opthalmology, Tongji Hospital

dr_zhanghong@vip.163.com+86 027-83662689

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026